1 day ago · As a result of these changes, two senior roles – President of Research and Development, held by Martin Mackay, and Executive Vice President, Global Commercial, held by Tony Zook – have been...

Apr 21, 2020 · Former senior executive at AstraZeneca and pharmaceutical industry expert to join as Independent Director; The Company is developing Vicromax(tm) – a broad-spectrum orally administered anti-viral candidate for COVID-19 ; Upon receipt of FDA approval, Phase II clinical trial is planned to be conducted at Mayo Clinic

Jan 15, 2013 · Martin Mackay and Tony Zook will leave the company at the end of January. The full Senior Executive Team is as follows: The appointment of Executive Vice President, Global Portfolio & Product Strategy will be made at a later date.

Anthony Zook Mr. Zook has a wealth of commercialization experience in the life science industry gained primarily through his career at AstraZeneca Plc. Mr. Zook held several executive positions at AstraZeneca, including Executive Vice President of Global Commercial Operations from 2010 to 2013, President and Chief Executive Officer of the North ...

ATHLONE, Ireland, Dec. 8, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) today announced that Tony Zook, formerly executive vice president, Global Commercial Operations, at AstraZeneca,...

Jan 10, 2025 · Prior to his extensive consulting work and role as CEO of Innocoll Pharmaceuticals, Zook was Executive Vice President of Global Commercial Operations at AstraZeneca (AZ), where he held global P&L responsibility for all of AZ’s brands and markets, representing over $30 billion in revenues.

Sep 20, 2005 · Tony Zook has been named to head the U.S. operations of AstraZeneca. Zook has more than 20 years experience and is currently AstraZeneca's senior vice president for U.S. commercial...

Jan 10, 2025 · Replacing Smith is Tony Zook, appointed CEO effective April 1, 2025. Zook's annual base salary will be $850,000, plus a target bonus of 100% of his salary, and roughly $8 million in equity awards. Zook brings extensive experience from AstraZeneca, where he oversaw over $30 billion in revenue, and from his role as CEO of Innocoll Pharmaceuticals.

Jul 1, 2020 · Zook held several executive positions at AstraZeneca, including Executive Vice President of Global Commercial Operations from 2010 to 2013, President and Chief Executive Officer of the North American division from 2007 to 2010 and President of Medimmune, the wholly-owned biologics division of AstraZeneca, from 2008 to 2010.